Q&A: 37% of IBS patients surveyed say COVID-19 makes managing symptoms difficult

Q&A: 37% of IBS patients surveyed say COVID-19 makes managing symptoms difficult

Salix Pharmaceuticals recently released survey results in a report, Patient Perspectives: Living with IBS in a Pandemic. offering perspectives from adults with irritable bowel syndrome during the COVID-19 pandemic.Healio Gastroenterology spoke with Howard Franklin, MD, MBA, chief medical officer at Salix Pharmaceuticals, about the survey results and the importance of communication between health care providers and their patients with IBS.Healio: What were some of the key results from this IBS survey?Franklin: More than one-third — almost 37% of IBS patients surveyed — reportedRead More

Share on facebook
Share on twitter
Share on linkedin